412 related articles for article (PubMed ID: 26071912)
1. Predictors of adverse neonatal outcomes in intrahepatic cholestasis of pregnancy.
Kawakita T; Parikh LI; Ramsey PS; Huang CC; Zeymo A; Fernandez M; Smith S; Iqbal SN
Am J Obstet Gynecol; 2015 Oct; 213(4):570.e1-8. PubMed ID: 26071912
[TBL] [Abstract][Full Text] [Related]
2. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses.
Ovadia C; Seed PT; Sklavounos A; Geenes V; Di Ilio C; Chambers J; Kohari K; Bacq Y; Bozkurt N; Brun-Furrer R; Bull L; Estiú MC; Grymowicz M; Gunaydin B; Hague WM; Haslinger C; Hu Y; Kawakita T; Kebapcilar AG; Kebapcilar L; Kondrackienė J; Koster MPH; Kowalska-Kańka A; Kupčinskas L; Lee RH; Locatelli A; Macias RIR; Marschall HU; Oudijk MA; Raz Y; Rimon E; Shan D; Shao Y; Tribe R; Tripodi V; Yayla Abide C; Yenidede I; Thornton JG; Chappell LC; Williamson C
Lancet; 2019 Mar; 393(10174):899-909. PubMed ID: 30773280
[TBL] [Abstract][Full Text] [Related]
3. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial.
Chappell LC; Bell JL; Smith A; Linsell L; Juszczak E; Dixon PH; Chambers J; Hunter R; Dorling J; Williamson C; Thornton JG;
Lancet; 2019 Sep; 394(10201):849-860. PubMed ID: 31378395
[TBL] [Abstract][Full Text] [Related]
4. Society for Maternal-Fetal Medicine Consult Series #53: Intrahepatic cholestasis of pregnancy: Replaces Consult #13, April 2011.
; Lee RH; Mara Greenberg ; Metz TD; Pettker CM
Am J Obstet Gynecol; 2021 Feb; 224(2):B2-B9. PubMed ID: 33197417
[TBL] [Abstract][Full Text] [Related]
5. Beyond stillbirth: association of intrahepatic cholestasis of pregnancy severity and adverse outcomes.
Sarker M; Zamudio AR; DeBolt C; Ferrara L
Am J Obstet Gynecol; 2022 Sep; 227(3):517.e1-517.e7. PubMed ID: 36008054
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy course in patients with intrahepatic cholestasis of pregnancy treated with very low doses of ursodeoxycholic acid.
Grymowicz M; Czajkowski K; Smolarczyk R
Scand J Gastroenterol; 2016 Jan; 51(1):78-85. PubMed ID: 26152830
[TBL] [Abstract][Full Text] [Related]
7. Obstetric cholestasis: outcome with active management.
Roncaglia N; Arreghini A; Locatelli A; Bellini P; Andreotti C; Ghidini A
Eur J Obstet Gynecol Reprod Biol; 2002 Jan; 100(2):167-70. PubMed ID: 11750958
[TBL] [Abstract][Full Text] [Related]
8. Ursodeoxycholic acid versus placebo in the treatment of women with intrahepatic cholestasis of pregnancy (ICP) to improve perinatal outcomes: protocol for a randomised controlled trial (PITCHES).
Chappell LC; Chambers J; Dixon PH; Dorling J; Hunter R; Bell JL; Bowler U; Hardy P; Juszczak E; Linsell L; Rounding C; Smith A; Williamson C; Thornton JG
Trials; 2018 Nov; 19(1):657. PubMed ID: 30482254
[TBL] [Abstract][Full Text] [Related]
9. Fetal cardiac dysfunction in intrahepatic cholestasis of pregnancy is associated with elevated serum bile acid concentrations.
Vasavan T; Deepak S; Jayawardane IA; Lucchini M; Martin C; Geenes V; Yang J; Lövgren-Sandblom A; Seed PT; Chambers J; Stone S; Kurlak L; Dixon PH; Marschall HU; Gorelik J; Chappell L; Loughna P; Thornton J; Pipkin FB; Hayes-Gill B; Fifer WP; Williamson C
J Hepatol; 2021 May; 74(5):1087-1096. PubMed ID: 33276032
[TBL] [Abstract][Full Text] [Related]
10. Women successfully treated for severe intrahepatic cholestasis of pregnancy do not have increased risks for adverse perinatal outcomes.
Yang J; Chen C; Liu M; Zhang S
Medicine (Baltimore); 2019 Jul; 98(27):e16214. PubMed ID: 31277130
[TBL] [Abstract][Full Text] [Related]
11. Risk-stratified management strategies for intrahepatic cholestasis of pregnancy: A tertiary center population review over nearly 5 years.
Xu T; Zhan Y; Chen D; Deng X; Mao C; Xu J; Wang X; Guo B; Wang X
Int J Gynaecol Obstet; 2024 Jan; 164(1):219-226. PubMed ID: 37470272
[TBL] [Abstract][Full Text] [Related]
12. Intrahepatic cholestasis of pregnancy: observational study of the treatment with low-dose ursodeoxycholic acid.
Joutsiniemi T; Timonen S; Linden M; Suvitie P; Ekblad U
BMC Gastroenterol; 2015 Jul; 15():92. PubMed ID: 26215400
[TBL] [Abstract][Full Text] [Related]
13. Predictors of adverse perinatal outcomes in intrahepatic cholestasis of pregnancy with dichorionic diamniotic twin pregnancies.
Mei Y; Gao L; Lin Y; Luo D; Zhou X; He L
J Matern Fetal Neonatal Med; 2019 Feb; 32(3):472-476. PubMed ID: 29020816
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study).
Kong X; Kong Y; Zhang F; Wang T; Yan J
Medicine (Baltimore); 2016 Oct; 95(40):e4949. PubMed ID: 27749550
[TBL] [Abstract][Full Text] [Related]
15. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a systematic review and individual participant data meta-analysis.
Ovadia C; Sajous J; Seed PT; Patel K; Williamson NJ; Attilakos G; Azzaroli F; Bacq Y; Batsry L; Broom K; Brun-Furrer R; Bull L; Chambers J; Cui Y; Ding M; Dixon PH; Estiú MC; Gardiner FW; Geenes V; Grymowicz M; Günaydin B; Hague WM; Haslinger C; Hu Y; Indraccolo U; Juusela A; Kane SC; Kebapcilar A; Kebapcilar L; Kohari K; Kondrackienė J; Koster MPH; Lee RH; Liu X; Locatelli A; Macias RIR; Madazli R; Majewska A; Maksym K; Marathe JA; Morton A; Oudijk MA; Öztekin D; Peek MJ; Shennan AH; Tribe RM; Tripodi V; Türk Özterlemez N; Vasavan T; Wong LFA; Yinon Y; Zhang Q; Zloto K; Marschall HU; Thornton J; Chappell LC; Williamson C
Lancet Gastroenterol Hepatol; 2021 Jul; 6(7):547-558. PubMed ID: 33915090
[TBL] [Abstract][Full Text] [Related]
16. Corticotropin-releasing hormone expression in patients with intrahepatic cholestasis of pregnancy after ursodeoxycholic acid treatment: an initial experience.
Zhou F; Zhang L; He MM; Liu ZF; Gao BX; Wang XD
Curr Med Res Opin; 2014 Aug; 30(8):1529-35. PubMed ID: 24665980
[TBL] [Abstract][Full Text] [Related]
17. Cholestasis: A Prospective Study of Perinatal Outcomes and Time to Symptom Improvement.
Yule CS; Holcomb DS; Kraus AC; Brown CEL; McIntire DD; Nelson DB
Am J Perinatol; 2021 Apr; 38(5):414-420. PubMed ID: 32971564
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of predictive value of biochemical markers for adverse obstetrics outcomes in pregnancies complicated by cholestasis.
Guszczynska-Losy M; Wirstlein PK; Wender-Ozegowska E; Kedzia M
Ginekol Pol; 2020; 91(5):269-276. PubMed ID: 32495933
[TBL] [Abstract][Full Text] [Related]
19. The importance of serum bile acid level analysis and treatment with ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a case series from central Europe.
Ambros-Rudolph CM; Glatz M; Trauner M; Kerl H; Müllegger RR
Arch Dermatol; 2007 Jun; 143(6):757-62. PubMed ID: 17576942
[TBL] [Abstract][Full Text] [Related]
20. Early induction of labor in high-risk intrahepatic cholestasis of pregnancy: what are the costs?
Friberg AK; Zingmark V; Lyndrup J
Arch Gynecol Obstet; 2016 Oct; 294(4):709-14. PubMed ID: 26825731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
